Case Study: Chronic Renal Insufficiency — Creatinine Dropped 21% in 1 Month with CDS (Laboratory Evidence)
Patient Profile
- **Name:** Sergio Resendiz Vega
- **Age:** 51 years old
- **Attending Physician:** Dr. Raúl Rodríguez
- **Laboratory:** COVA Laboratorio, Av. Convento Santa Mónica 101, Jardines de Santamónica
Background
The patient suffers from chronic renal insufficiency and was on hemodialysis. After contracting COVID-19, his wife began treating him with CDS and DMSO, including intravenous CDS.
The wife reports: "Using CDS, my husband's creatinine has gone down."
Laboratory Results — Comparison
| Test | Sept 5, 2020 | Oct 6, 2020 | Normal Range (Men) | Change | |------|-------------|-------------|-------------------|--------| | **Creatinine** | **13.95 mg/dL** | **11.00 mg/dL** | 0.7–1.4 | **↓ 21.1% reduction** | | **Urea** | **139.0 mg/dL** | **108.0 mg/dL** | 17–43 | **↓ 22.3% reduction** | | **BUN** | **65 mg/dL** | **50 mg/dL** | 8–20 | **↓ 23.1% reduction** | | **Uric Acid** | **7.4 mg/dL** | **5.3 mg/dL** | 3.5–7.7 | Normalized | | HDL Cholesterol | 39.00 mg/dL | 50.00 mg/dL | — | ↑ Improved | | LDL Cholesterol | 110.80 mg/dL | 105.40 mg/dL | <150 | ↓ Improved | | Atherogenic Index | 4.31 | 3.60 | ≤4.5 | ↓ Improved |
Protocol Applied
- **CDS (oral)** — daily
- **CDS (intravenous)** — administered separately from oral dose
- **DMSO** — applied topically
- **Protocol K** — DMSO + CDS applied to bladder area through abdomen
The wife notes that the COVID infection was "a blessing" because it led them to increase the CDS dosage and begin intravenous administration.
Results
Within approximately one month of CDS treatment:
- Creatinine dropped **21.1%** (13.95 → 11.00 mg/dL)
- Urea dropped **22.3%** (139.0 → 108.0 mg/dL)
- BUN dropped **23.1%** (65 → 50 mg/dL)
- Uric acid normalized (7.4 → 5.3 mg/dL)
- HDL cholesterol improved (39 → 50 mg/dL)
- Patient resumed urinating
- Urinary tract infection cleared (Enterococcus Faecalis eliminated)
While kidney values remain elevated (consistent with chronic renal insufficiency requiring hemodialysis), the significant downward trend in all three key renal markers demonstrates measurable improvement in kidney function with CDS treatment.
Source
Personal testimonial with laboratory evidence via Telegram. Published with permission.